Tags : Johnson and Johnson

Top 20 Biopharma Acquisitions of 2018 Based on the Total

Biopharma acquisition activity in 2018 shows a significant increase over the previous year. Takeda proved to be on top with the acquisition of Shire among the top 20 acquisitions with a total deal value of $57.17B strengthening its capabilities in gastroenterology, neuroscience, oncology, rare diseases, and plasma-derived therapies. This article is based on the 2018 […]Read More

Everyday Health Group to Acquire Johnson and Johnson’s BabyCenter a

Shots: Everyday Health acquires BabyCenter combining its What to Expect digital pregnancy and parenting platform, with the focus of supporting parents through the journey of pregnancy and early parenting plus combined expertise for engaging digital experiences of parenthood What to Expect is Everyday Health’s first rated digital pregnancy app in the Apple Store, awarded under […]Read More

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

The increasing cases of autoimmune disorders such as rheumatoid arthritis are driving the growth of immunology products in the global market. Multiple companies have been focusing on Oncology, Hematology and multiple diseases but due to a drastic increase in the immune disorders, Immunology segment has been widely spared across the globe. In the top 20 […]Read More

Insights+: An Analysis of Biopharma Companies Growth in Last 20

In the last 20 years the global Biopharma space has changed a lot with ups and downs of companies and their growth. This analysis has found the multiple acquisitions and mergers along with the launch of several blockbusters leading to jump in growth and revenue of numerous companies. Pfizer acquired Warner-Lambert in 2000 to gain […]Read More